FogPharma Alternatives & Competitors
12 companies similar to FogPharma — Until everything is druggable.
Companies similar to FogPharma
Gensun Biopharma
We are dedicated to the discovery and development of innovative biological therapeutics fo...
United States
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
Rival Readout
Competing with FogPharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Breakpoint Therapeutics
Modulating DNA damage responses to cure cancer
Hamburg, Germany
Treeline
Making medicines at the highest level
Watertown, United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
About FogPharma
FogPharma, founded in 2016 and headquartered in the United States, is at the forefront of revolutionizing drug development. Operating within the Biopharma, Biotechnology, Health Care, Life Sciences, and Pharmaceutical industries, their slogan, "Until everything is druggable," encapsulates their ambitious mission. The c...
development of ultra-tunable peptide therapeutics, research and development of novel cancer treatments, platform for drug discovery and innovation
patients with severe diseases, healthcare providers treating cancer and desmoid tumors, research institutions and collaborators in oncology
Drug Discovery, Helicon Peptides, Precision Medicine, Cell-penetrating Peptides, Oncology, Cancer Treatment, Novel Drug Development, Therapeutics, Monoclonal Antibodies, Small Molecules, Undruggable Targets, Entrepreneurial Innovation, Cancer Biology
B2B, B2D, Platform
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around FogPharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at FogPharma on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
